Kyntra Bio, Inc. · NASDAQ:KYNB
Wettig Thane received 2,500 Kyntra Bio, Inc. shares as an award (Form 4)
Traded Nov 15, 2026 · Filed Nov 17, 2026
On Nov 15, 2026, Wettig Thane (Director, CEO) received 2,500 Kyntra Bio, Inc. shares as an award at US$2.92 for US$7,310, leaving 29,296 shares. Filed Nov 17, 2026 (Form 4).
- Awarded
- 2,500 shares
- Price
- US$2.92
- Value
- US$7,310
- Holding after
- 29,296 shares
- Trading plan
- No
- Role
- Director, CEO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Nov 15, 2026 | Common Stock | Award | 2,500 | US$2.92 | 29,296 | Direct |
Source
Download original · View original at SEC
Related
- Kyntra Bio, Inc.
- Wettig Thane
- Kyntra Bio, Inc. shareholders
- Form 4 · Wettig Thane · Sep 9, 2026
- Form 4 · Wettig Thane · Jun 9, 2026
- Form 4/A · Wettig Thane · May 19, 2026
- Schedule 13G/A · Armistice Capital, LLC · Nov 16, 2026
- Form 4 · DeLucia David · Sep 9, 2026
- Schedule 13G/A · Armistice Capital, LLC · Aug 14, 2026
- Form 4 · DeLucia David · Jun 9, 2026
- Schedule 13G/A · Armistice Capital, LLC · May 15, 2026